To.

Slides:



Advertisements
Similar presentations
CE REVIEW UNDERSTANDING HYPERTENSION. Hypertension is a chronic medical condition affecting more than 65 million Americans. Controlling hypertension is.
Advertisements

Task Force on Diabetes and CVD (ESC and EASD) European Heart Journal 2007;28:
1 Excess Dietary Sodium: Impact on Hypertension and Health Outcomes Presenters name Institution Updated April 2011.
Bridget Dillon February 11,  Cardiovascular disease affects the heart and circulatory system. It is often a result of blockages of blood vessels.
Absolute cardiovascular disease risk Assessment and Early Intervention Dr Michael Tam Lecturer in Primary Care
 Currently 150 Million people worldwide suffering from diabetes and that number may double by the year  The prevalence of type 2 diabetes is dramatically.
Stroke Issues & prevention. Agenda  Impact of Stroke –Definitions –Epidemiology –Risk factors  Management of Stroke –Acute management –Primary & Secondary.
Stress and Health. Psychological Factors Affecting a Medical Condition A general medical condition Psychological factors adversely affect the general.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and
The concept of Diabetes & CV risk: A lifetime risk challenge
By Cyneetha Strong, MD May 19,  Diseases and conditions pertaining to the heart and vascular (blood vessels) system  Primarily includes heart.
Hypertension (high blood pressure) Dr. Fiona Gillan GP Registrar at Church End Medical Centre.
Non-communicable diseases A global overview David Leon.
Management of Hypertension according to JNC 7 BY SANDAR KYI, MD.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
What is Diabetes? Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively.
Health Disparities in Cardiovascular Disease Paula A. Johnson, MD, MPH Chief, Division of Women’s Health; Executive Director, Connors Center for Women’s.
Tt HRB Centre for Health and Diet Research The burden of hypertension Ivan J Perry, Dept. of Epidemiology and Public Health, University College Cork. Institute.
Hypertension as a Public Health Risk
Hypertension By Dr. Nagwa Eid Saad Prof. Of Internal Medicine & Family Medicine In Cairo University.
Drugs for Hypertension
Non-communicable diseases David Redfern
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Global impact of ischemic heart disease World Heart Federation, 2011.
20 Cardiovascular Disease and Physical Activity chapter.
METABOLIC Syndrome: a Global Perspective
Systemic Hypertension. Systemic blood pressure measures 140/90 mm Hg or higher on at least two occasions a minimum of 1 to 2 weeks apart.
William B. Kannel, MD, FACC Former Director, Framingham Heart Study
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Cardiovascular Disease in Women Module I: Epidemiology.
Dr. Atapour Nephrologist. Hypertension Blood pressure levels are a function of cardiac output multiplied by peripheral resistance (the resistance in.
HYPERTENSION BURDEN AND CVD RISK PREDICTION IN AFRICA.
Hypertension the Community - Overview HYPERTENSION IN THE COMMUNITY: OVERVIEW.
Reducing Risk of Heart Disease & Stroke - A Life Long Quest Jeffrey P. Gold, M.D. University of Toledo Medical Center.
Epidemiology of CVD in the Elderly Karen P. Alexander MD Duke University Medical Center Duke Clinical Research Institute Disclosures: (1) Minor Research:
FAME HTN Mohsen. Epidemiology and stuff  About 1/3 of middle aged patients have hypertension  About ½ of elderly patients have hypertension.  Responsible.
1 Hypertension Overview. 2 Leading Risks For Death (World Health Organization 2002) Cholesterol Alcohol HYPERTENSION Tobacco use Overweight.
Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal
The Cost Savings and Enhancements of a District’s Wellness Program A Case Study from Broward Presented by: Kay Blake, Training Supervisor Tina Severance-Fonte,
Investigations: Urine examination. Urine examination. Serum K. Serum K. Serum creatinine. Serum creatinine. Blood Sugar. Blood Sugar. Hb. Hb.
1 Current & New treatment strategies to address CV Risk.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
7 April 2013 WORLD HEALTH DAY. World Health Day 2 On 7 April 1948, the World Health Organization (WHO) was created. Since then, WHO named April 7 as World.
Definition of the ‘health transition’ Trends of disease patterns in populations The 4 stages of the epidemiological transition The cardiovascular disease.
An aortic aneurysm can rupture (dissecting aneurysm) and cause massive blood loss, circulatory shock and rapid death.
Health Statistics and Informatics Non-communicable diseases A global overview.
2007 Hypertension as a Public Health Risk January, 2007.
The Burden of Chronic Diseases in the Developing World Stephen J. Spann, M.D., M.B.A. Professor and Chairman Department of Family and Community Medicine.
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
Finger Lakes Health Systems Agency RBA Healthcare Collaborative Understanding Blood Pressure Phyllis Jackson RN Community Engagement Specialist.
Global health in the news h/study-shows-spread-of-cigarettes-in- china.html?ref=health&_r=0.
Cardiovascular Risk: A global perspective
Management of Hypertension according to JNC 7
Dr John Cox Diabetes in Primary Care Conference Cork
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Hypertension guidelines What’s all the controversy about 2015
Drugs for Hypertension
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
Risk factor thresholds: their existence under scrutiny
Diabetes Health Status Report
Hypertension Update: How Low Shall We Go?
Systolic Blood Pressure Intervention Trial (SPRINT)
Progress and Promise in RAAS Blockade
Insights from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Fort Atkinson School District Wellness Program
Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010
Understanding Blood Pressure
Presentation transcript:

to

HYPERTENSION IN INDIA Dr. A. Muruganathan President - API Dr. M. Chenniappan Trichy Medical Writer

On the Occasion of World Hypertension Day... An API Initiative to upgrade knowledge of Practising physicians throughout India

Why ?

Educate Empower Easy learning Enjoyable learning Evaluate ownself 9912064435

The theme for World Hypertension Day 2013 is “Healthy Heart Beat - Healthy Blood Pressure”. Considering the fact that atrial fibrillation – arrhythmias is very common in people with hypertension, especially among older patients, the WHL executive board felt that it is important to improve the public awareness about atrial fibrillation – arrhythmias. In order to make it easier for the public to understand they have used the simple terminology – Heart Beat.

The objectives of the World Hypertension League are to promote the detection, control and prevention of arterial hypertension in populations. The World Hypertension League is a federation of leagues, societies, and other national bodies devoted to this goal. Bringing together and stimulating organizations committed to the control of hypertension is the goal of the WHL. The WHL is a division of the International Society of Hypertension (ISH), and is in official relations with the World Health Organization (WHO).

Benefit of Interventions Over 5 Years Lowering systolic BP 4 mm Hg: -12.5 cardiovascular events / 200 patients Lowering LDL cholesterol 1 mmol/L -8.2 cardiovascular events / 200 patients Lowering HbA1c 0.9 % -2.9 cardiovascular events / 200 patients

Prevalence1 Nearly 1 billion adults (more than a quarter of the world’s population) had hypertension in 2000, and this is predicted to increase to 1.56 billion by 2025. The prevalence of hypertension varies considerably from one region of India to another. In India, 23.10% men and 22.60% women over 25 years old suffer from hypertension, says the World Health Organization’s global health statistics 2012’ released in May, 2012. 1. Indian J Med Res 128, December 2008, pp 688-690

Prevalence Recent (2012) studies show that for every known person with hypertension in India, there may possibly be 2 persons with either undiagnosed hypertension or prehypertension. With over 139 million patients, India accounts for 15% of world’s uncontrolled hypertension patients.

Prevalence In terms of attributable deaths, the leading behavioral and physiological risk factors globally are raised blood pressure (to which 13% of global deaths are attributed), followed by tobacco use (9%), raised blood glucose (6%), physical inactivity (6%) and being overweight or obese (5%). It has been estimated that raised blood pressure causes 51% of stroke deaths and 45% of coronary heart disease deaths.

Global Mortality 2000: Impact of Hypertension and Other Health Risk Factors High blood pressure Tobacco High cholesterol Underweight Unsafe sex High BMI Physical inactivity High mortality, developing region Lower mortality, developing region Developed region Alcohol Indoor smoke from solid fuels Iron deficiency 1000 2000 3000 4000 5000 6000 7000 8000 Attributable Mortality (In thousands; total 55,861,000) Ezzati et al. Lancet. 2002;360:1347-1360.

Prevalence Only 1 in 5 hypertensive women were on treatment and less than 4% are controlled. Majority of hypertensive still remain undetected & the control of hypertension is also inadequate. But, despite all this, the good news is that the prevalence of hypertension in India is low as compared to world figures and India fares better than other countries in the South-East Asia Region (SEAR). SEAR’s average is - 25.40% in men & 24.20 in women.

Among the High Blood Pressure patients only one third are aware of the disease. Out of this only one third come for treatment. Out of this only one third of patients are under control.

An Analysis of NHANES III Blood Pressure Data Summary: Hypertensives fall into one of two categories: 1. A smaller (26%), younger (age < 50 years), predominantly male (63%) with diastolic hypertension out of proportion to systolic hypertension (primarily IDH and SDH) 2. A larger (74%), older (age ≥ 50 years), predominantly female (58%) with systolic hypertension out of proportion to diastolic hypertension (primarily ISH). Franklin et al. Hypertension 2001;37: 869-874

Pre-hypertension Pre-hypertension is defined as a systolic blood pressure reading between 120 and 139 and a diastolic blood pressure of 80 to 89. Nearly 50 % people have Pre Hypertension, accordingly to one study, 50 % of people above 50 years have high blood pressure. The category of pre-hypertension, was introduced to emphasize that persons whose blood pressure is >120/80 mm Hg are likely to progress to definite hypertension. It was also hoped that doctors will encourage persons with pre- hypertension to begin lifestyle modifications to prevent its progression to hypertension.

Members of the Association of Physicians of India (API) are planning to conduct screening camps and patient education regarding hypertension, complications and management with the help of IMA throughout the country. API is also interested to conduct updates for practicing physicians regarding the newer methods and updates about hypertension throughout the country directly and through web.

The Medical content of all 3 Modules has been written by Dr. M The Medical content of all 3 Modules has been written by Dr.M.Chenniappan (Trichy) The Panelist representing respective Regions and Key Members of API will review & give their suggestions on the Modules before it is uploaded in the www.apiindia.org site. Sessions on Modules 2 & 3 will be facilitated by respective Panelist/KOLs in respective Bimonthly period A book on Diabetic Hypertension will be released with the input & support of API Key Members & Panelists and will be presented to registered Drs for E-Hypertension Academy

Lifestyle Modification MODULE-1 Basics, Diagnosis and Lifestyle Modification

1: INTRODUCTION AND BASICS Introduction to hypertension e academics Epidemiology of hypertension in India – Incidence, Awareness , Control Etiopathogenesis of hypertension Classification

2: DIAGNOSIS OF HYPERTENSION Clinical examination in hypertension Measurement of blood pressure Ambulatory BP monitoring Laboratory investigation in hypertension Imaging in hypertension

3: NONPHARMACOLOGICAL APPROACH TO HYPERTENSION Goals and risk stratification Diet and hypertension Salt and hypertension Exercise and other lifestyle modifications

MODULE-2 Management of Hypertension

1: PHARMACOLOGICAL TREATMENT OF HYPERTENSION (Part 1) Classification of antihypertensive and their mechanism of action Selection of initial drugs in uncomplicated hypertension Selection of drugs according to compelling indications

2: PHARMACOLOGICAL TREATMENT OF HYPERTENSION (Part 2) Combination therapy Difficult to control hypertension and resistant hypertension – Approach Treatment of acute severe hypertension

3: INTERVENTIONAL THERAPY IN HYPERTENSION Renal artery Angioplasty Renal sympathetic denervation Baroreceptor stimulation Surgical approach to hypertension

MODULE-3 Target Organs and Special Situations

1: HYPERTENSION AND HEART Various cardiovascular changes in hypertension Hypertension and CAD Hypertension and HF (REF, PEF) Hypertension and atherosclerosis – vascular aging Cardiovascular emergencies in hypertension.

2: HYPERTENSION IN SPECIAL SITUATION Hypertension in extremes of age Hypertension and kidney Hypertension and lung disease Hypertension and CVA Pregnancy and Hypertension

3: EVIDENCE Important trials in Hypertension Meta analysis in Hypertension API – Indian hypertension guidelines

Patient Based Interactive Module (Optional) Patient Based Interactive Module

THE GOOD NEWS

reduction in cardiovascular risk with effective lowering of blood There is considerable reduction in cardiovascular risk with effective lowering of blood pressure with therapy.

Long-Term Antihypertensive Therapy Significantly Reduces CV Events Myocardial Stroke infarction Heart failure –10 –20 Average reduction in events (%) –30 20%-25% –40 35%-40% –50 >50% –60 Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet. 2000;355:1955-1964.

On Completion of all 3 Module Test, Practising Physician will be given “ Certificate of Participation from the house of API”

MODULE-1 1 B Hypertension in India

Diseases Attributable to Hypertension Gangrene of the Lower Extremities Heart Failure Left Ventricular Hypertrophy Myocardial Infarction Hypertensive Encephalopathy Aortic Aneurysm Blindness Chronic Kidney Failure Stroke Preeclampsia/Eclampsia Cerebral Hemorrhage Coronary Heart Disease Adapted from Dustan HP et al. Arch Intern Med. 1996; 156: 1926-1935

Attributable Mortality (In thousands; total 55,861,000) Global Mortality 2000: Impact of Hypertension and Other Health Risk Factors High blood pressure Tobacco High cholesterol Underweight Unsafe sex High BMI Physical inactivity High mortality, developing region Lower mortality, developing region Developed region Alcohol Indoor smoke from solid fuels Iron deficiency 1000 2000 3000 4000 5000 6000 7000 8000 Attributable Mortality (In thousands; total 55,861,000) Ezzati et al. Lancet. 2002;360:1347-1360.

Hypertension in India (1/2) Cardiovascular diseases caused 2.3 million deaths in India in the year 1990; Projected to double by the year 2020 Hypertension directly responsible for 57% of all stroke deaths and 24% of all coronary heart disease deaths in India Strong correlation between changing lifestyle factors and increase in hypertension in India The nature of genetic contribution and gene-environment interaction in accelerating the hypertension epidemic in India needs more studies Gupta R. J Hum Hypertens 2004;18:73-78

Hypertension in India (2/2) In India, hypertension is present in 25% urban and 10% rural subjects At an underestimate, there are 31.5 million hypertensives in rural and 34 million in urban populations A total of 70% of these would be Stage I hypertension (systolic BP 140-159 and/or diastolic BP 90-99 mmHg) Recent reports show that borderline hypertension (systolic BP 130-139 and/or diastolic BP 85-89 mmHg) and Stage I hypertension carry a significant cardiovascular risk Gupta R. J Hum Hypertens 2004;18:73-78

Risk Attributable due to Hypertension in India http://www.whoindia.org/SCN/AssBOD/08-Hypertension.pdf Accessed on 27th May 2010

Prevalence studies in India R Gupta :Journal of Human Hypertension (2004) 18, 73–78

Recent studies R Gupta :Journal of Human Hypertension (2004) 18, 73–78

R Gupta :Journal of Human Hypertension (2004) 18, 73–78

National Heath and Nutrition Survey, Percent TRENDS IN AWARENESS, TREATMENT AND CONTROL OF HIGH BLOOD PRESSURE 1976-2000 National Heath and Nutrition Survey, Percent 1976-80 1988-91 1991-94 1999-2000 Awareness 51 73 68 70 Treatment 31 55 54 59 Control 10 29 27 34 In India and surrounding countries, awareness level is ≤ 45%. Only 50% of these are on treatment and BP control rates are very poor.

Trends in BP Control in India (1/2) % of uncontrolled hypertensive patients Only 27.3% patients had both SBP and DBP under control Survey in hypertensive patients (n=3402) receiving antihypertensive medications Hathial M. J Indian Med Assoc. 2007; 105 (7): 401-2, 404, 410.

% of hypertensive patients achieving BP goal Trends in BP Control in India (2/2) % of hypertensive patients achieving BP goal Study conducted in Chennai, of the treated hypertensive patients (n=154), only 45.9% of patients had their BP under control (i.e. <140/90 mm Hg). Similar analysis done in diabetic hypertension patients (n=149) showed that of the patients that were treated for hypertension, only 51.1% had their blood pressure under control. Mohan V et al. JAPI 2007; 55: 326-32.

Control of Hypertension in Indian population Undiagnosed hypertension 67.2% Diagnosed hypertension 32.8% Treated hypertension 29.2% Untreated hypertension 70.8% Hypertensive 20% Normotensive 80% Controlled hypertension Uncontrolled hypertension …only 15.4% of total hypertensive group have blood pressure controlled Mohan:J Assoc Physicians India, 2007 May;55:326-32

END OF MODULE-1 1B